Emily J. Rendleman

3.7k total citations
29 papers, 1.7k citations indexed

About

Emily J. Rendleman is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Emily J. Rendleman has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 4 papers in Genetics and 2 papers in Hematology. Recurrent topics in Emily J. Rendleman's work include Genomics and Chromatin Dynamics (15 papers), Epigenetics and DNA Methylation (14 papers) and Cancer-related gene regulation (12 papers). Emily J. Rendleman is often cited by papers focused on Genomics and Chromatin Dynamics (15 papers), Epigenetics and DNA Methylation (14 papers) and Cancer-related gene regulation (12 papers). Emily J. Rendleman collaborates with scholars based in United States, Japan and China. Emily J. Rendleman's co-authors include Ali Shilatifard, Stacy A. Marshall, Marc A. Morgan, Edwin R. Smith, Patrick A. Ozark, Kaixiang Cao, Andrea Piunti, Clayton K. Collings, Elizabeth T. Bartom and Yuki Aoi and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Emily J. Rendleman

29 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily J. Rendleman United States 22 1.5k 184 146 132 105 29 1.7k
Stacy A. Marshall United States 23 1.8k 1.2× 168 0.9× 189 1.3× 150 1.1× 131 1.2× 26 2.0k
Andrea Piunti United States 21 1.7k 1.1× 295 1.6× 278 1.9× 212 1.6× 174 1.7× 34 2.0k
Sven Fraterman Germany 11 973 0.6× 57 0.3× 84 0.6× 121 0.9× 131 1.2× 11 1.2k
Stephanie Lerach United States 9 901 0.6× 203 1.1× 154 1.1× 131 1.0× 310 3.0× 13 1.5k
Kelly Morgan United States 13 1.1k 0.7× 172 0.9× 97 0.7× 98 0.7× 179 1.7× 25 1.3k
Etienne Danis United States 18 1.0k 0.7× 53 0.3× 232 1.6× 141 1.1× 323 3.1× 40 1.4k
Stan L. Lilleberg United States 10 629 0.4× 217 1.2× 81 0.6× 149 1.1× 119 1.1× 15 909
Caterina Marchetti Italy 7 748 0.5× 173 0.9× 118 0.8× 51 0.4× 179 1.7× 8 1.1k
Anne Laugesen Denmark 8 1.1k 0.7× 41 0.2× 192 1.3× 161 1.2× 71 0.7× 9 1.3k

Countries citing papers authored by Emily J. Rendleman

Since Specialization
Citations

This map shows the geographic impact of Emily J. Rendleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily J. Rendleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily J. Rendleman more than expected).

Fields of papers citing papers by Emily J. Rendleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily J. Rendleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily J. Rendleman. The network helps show where Emily J. Rendleman may publish in the future.

Co-authorship network of co-authors of Emily J. Rendleman

This figure shows the co-authorship network connecting the top 25 collaborators of Emily J. Rendleman. A scholar is included among the top collaborators of Emily J. Rendleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily J. Rendleman. Emily J. Rendleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Zibo, et al.. (2022). CARM1-mediated methylation of ASXL2 impairs tumor-suppressive function of MLL3/COMPASS. Science Advances. 8(40). eadd3339–eadd3339. 11 indexed citations
2.
Zhu, Pei, Emily J. Rendleman, Nabiha Khan, et al.. (2022). BMAL1 drives muscle repair through control of hypoxic NAD+ regeneration in satellite cells. Genes & Development. 36(3-4). 149–166. 26 indexed citations
3.
Morgan, Marc A., Irina K Popova, Anup Vaidya, et al.. (2021). A trivalent nucleosome interaction by PHIP/BRWD2 is disrupted in neurodevelopmental disorders and cancer. Genes & Development. 35(23-24). 1642–1656. 17 indexed citations
4.
Wang, Lu, Zibo Zhao, Patrick A. Ozark, et al.. (2021). Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function mutated leukemia. Nature Cancer. 2(5). 515–526. 49 indexed citations
5.
Zheng, Bin, Yuki Aoi, Avani P. Shah, et al.. (2021). Acute perturbation strategies in interrogating RNA polymerase II elongation factor function in gene expression. Genes & Development. 35(3-4). 273–285. 36 indexed citations
6.
Cao, Kaixiang, Patrick A. Ozark, Juan Wang, et al.. (2020). DOT1L-controlled cell-fate determination and transcription elongation are independent of H3K79 methylation. Proceedings of the National Academy of Sciences. 117(44). 27365–27373. 42 indexed citations
7.
Aoi, Yuki, Edwin R. Smith, Avani P. Shah, et al.. (2020). NELF Regulates a Promoter-Proximal Step Distinct from RNA Pol II Pause-Release. Molecular Cell. 78(2). 261–274.e5. 112 indexed citations
8.
Rickels, Ryan, Marta Iwanaszko, Patrick A. Ozark, et al.. (2020). A small UTX stabilization domain of Trr is conserved within mammalian MLL3-4/COMPASS and is sufficient to rescue loss of viability in null animals. Genes & Development. 34(21-22). 1493–1502. 18 indexed citations
9.
Rosencrance, Celeste, et al.. (2020). Chromatin Hyperacetylation Impacts Chromosome Folding by Forming a Nuclear Subcompartment. Molecular Cell. 78(1). 112–126.e12. 57 indexed citations
10.
Katagi, Hiroaki, Nozomu Takata, Yuki Aoi, et al.. (2020). DIPG-03. THERAPEUTIC TARGETING OF TRANSCRIPTIONAL ELONGATION IN DIFFUSE INTRINSIC PONTINE GLIOMA. Neuro-Oncology. 22(Supplement_3). iii287–iii287. 1 indexed citations
11.
Sze, Christie C., Caila Ryan, Andrea Piunti, et al.. (2020). Uncoupling histone H3K4 trimethylation from developmental gene expression via an equilibrium of COMPASS, Polycomb and DNA methylation. Nature Genetics. 52(6). 615–625. 69 indexed citations
12.
Cao, Kaixiang, Clayton K. Collings, Marc A. Morgan, et al.. (2018). An Mll4/COMPASS-Lsd1 epigenetic axis governs enhancer function and pluripotency transition in embryonic stem cells. Science Advances. 4(1). eaap8747–eaap8747. 48 indexed citations
13.
Liang, Kaiwei, Edwin R. Smith, Yuki Aoi, et al.. (2018). Targeting Processive Transcription Elongation via SEC Disruption for MYC-Induced Cancer Therapy. Cell. 175(3). 766–779.e17. 86 indexed citations
14.
Zhao, Zibo, Lu Wang, Andrew Volk, et al.. (2018). Regulation of MLL/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia. Genes & Development. 33(1-2). 61–74. 25 indexed citations
15.
Wang, Lu, Zibo Zhao, Patrick A. Ozark, et al.. (2018). Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. Nature Medicine. 24(6). 758–769. 121 indexed citations
16.
Cao, Kaixiang, Clayton K. Collings, Stacy A. Marshall, et al.. (2017). SET1A/COMPASS and shadow enhancers in the regulation of homeotic gene expression. Genes & Development. 31(8). 787–801. 43 indexed citations
17.
Rickels, Ryan, Hans-Martin Herz, Christie C. Sze, et al.. (2017). Histone H3K4 monomethylation catalyzed by Trr and mammalian COMPASS-like proteins at enhancers is dispensable for development and viability. Nature Genetics. 49(11). 1647–1653. 143 indexed citations
18.
Sze, Christie C., Kaixiang Cao, Clayton K. Collings, et al.. (2017). Histone H3K4 methylation-dependent and -independent functions of Set1A/COMPASS in embryonic stem cell self-renewal and differentiation. Genes & Development. 31(17). 1732–1737. 74 indexed citations
19.
Piunti, Andrea, Rintaro Hashizume, Marc A. Morgan, et al.. (2017). Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas. Nature Medicine. 23(4). 493–500. 275 indexed citations
20.
Morgan, Marc A., Ryan Rickels, Clayton K. Collings, et al.. (2017). A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation. Genes & Development. 31(19). 2003–2014. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stacy A. Marshall Breakdown of academic impact, for papers by Andrea Piunti Breakdown of academic impact, for papers by Sven Fraterman Breakdown of academic impact, for papers by Stephanie Lerach Breakdown of academic impact, for papers by Kelly Morgan Breakdown of academic impact, for papers by Etienne Danis Breakdown of academic impact, for papers by Stan L. Lilleberg Breakdown of academic impact, for papers by Caterina Marchetti Breakdown of academic impact, for papers by Anne Laugesen
Rankless by CCL
2026